Summary To investigate the cell biological function of PU.1, a member of the Ets family of transcription factors, a vector capable of expressing the protein was transfected into HT1080 human fibrosarcoma cells. Exogenous expression of PU.1 in HT1080 cells reduced colony-forming efficiency but stimulated cell migration in soft agar, although it did not affect cell growth in adherent culture. Expression of the urokinase-type plasminogen activator (uPA) mRNA, which is known to be correlated with cell migration and invasion, was enhanced in PU. 1 transfectants compared with mock transfectants. Run-on analysis demonstrated that uPA transcription was unaffected by PU.1, suggesting that this enhancement mainly occurs at a post-transcriptional level. On the other hand, treatment of HT1080 cells with the synthetic glucocorticoid dexamethasone (DEX; 10-7 M) significantly reduced uPA gene expression at a transcriptional level. Furthermore, DEX inhibited cell migration in soft agar without affecting cell growth. These negative effects of DEX on uPA expression and cell migration were alleviated by the expression of PU.1 in HT1080 cells, whereas expression of the N-ras oncogene, which is responsible for maintenance of the transformed phenotypes in HT1080 cells, was unaffected by PU.1 expression or DEX treatment in the cells. Our results suggest that expression of PU.1 can stimulate uPA gene expression at the post-transcriptional level, which may subsequently lead to activation of cell motility and/or reduced cell-cell adhesion, but reduces anchorage-independent growth of HT1080 cells.
PU. 1 is a member of the Ets family of transcription factors and is expressed in B cells and macrophages (Klemsz et al, 1990) . The protein activates several promoters and enhancers of various genes in B-cell and myelomonocytic cell lineages (Moreau-Gachelin, 1994; Simon et al, 1996) . PU.l is not expressed in mature T cells or erythroid cells. In Friend virus-induced mouse erythroleukaemia (MEL) cells, however, expression of the PU. I/Spi-1 gene is activated by proviral insertion of spleen focusforming virus (SFFV) (Moreau-Gachelin et al, 1988; Paul et al, 1991) . It has been proposed that the enhanced and constitutive expression of the PU. I gene in erythroid cells exerts a role in the neoplastic process by blocking differentiation of erythroblasts (Shuetze et al, 1993; Moreau-Gachelin et al, 1996) . We previously reported that overexpression of the PU. I gene in MEL cells blocks cell differentiation, inhibits cell growth and induces apoptosis in the presence of dimethylsulphoxide (DMSO) (Yamada et al, 1997) . These results suggest that the gene exerts versatile effects on transformed phenotypes.
In this report, we attempted to investigate the possible effect of PU. 1 on the transformed phenotypes other than in haematopoietic cells. We ectopically expressed the PU.] gene in a human fibrosarcoma cell line, HT1080, harbouring the activated N-ras gene and observed alterations of the biological phenotypes.
MATERIALS AND METHODS
Plasmid construction A 1.2-kb mouse PU.] full-length cDNA (Klemsz et al, 1990) , kindly donated by Dr D. Kabat, was cloned into an eukaryotic expression vector, pLRNL (Hung et al, 1988) , downstream of the MuLV promoter.
Cell culture and transfection
Two subclones, NM-1 and cl-2, were isolated from a human fibrosarcoma cell line, HT1080, purchased from the American Type Culture Collection. Cells were maintained in Dulbecco's modified Eagle minimum essential medium (DMEM) supplemented with 10% fetal bovine serum (FBS). The cells were transfected with the PU. I expression vector using Lipofectin reagent (Gibco/BRL) and transfectants were selected in the medium containing G418 (1 mg ml-').
Western blot analysis
Proteins were electrophoresed in a 12% sodium dodecyl sulphate (SDS)-polyacrylamide gel and transferred electrophoretically on to a nylon membrane (Immobilon; Millipore). The blot was probed with anti-PU. 1 polyclonal antibody (Santa Cruz). Chemiluminescent signals of the immunoreactive proteins were visualized on an X-ray film using the ECL kit (Amersham). 
DNA probes
An EcoRI fragment of human N-ras cDNA (Taparowsky et al, 1983) was derived from the Japanese Collection of Research Biosources-Gene (Tokyo, Japan). A PstI fragment of human urokinase cDNA (Veder et al, 1984) was derived from the American Type Culture Collection (ATCC; Rockville, MD, USA).
Northern blot analysis
Total RNA (10 lOtg) extracted from cells was denatured and electrophoresed in 1.2% agarose gels containing 0.66 M formaldehyde. Hybridization was performed as described (Kondoh et al, 1992) using cDNA probes labelled with [32p] ox-dCTP by the method of Feinberg and Vogelstein (1983) . Specific hybridization Nuclear run-on assay A nuclear run-on assay was performed as described (Kondoh et al. 1991) . Filters were blotted with 5 tg of PstI fragment of human urokinase cDNA and 5 ,ug of BamHI/EcoRI fragment of human cardiac actin DNA (Gunning et al, 1984) . Specific hybridization was visualized and band intensity was measured by the BAS-2000 image analysing system (Fuji Film, Tokyo, Japan).
RESULTS

Expression of PU.1 protein in PU.1-transfected HT1080 cells
To examine cell biological function of PU. Figure 2A and B respectively. Other PU.I transfectants also exhibited similar growing patterns to NMPU. 1-7 (data not shown). In spite of the difference in growth patterns in soft agar, no particular morphological alterations were observed between PU.] transfectants and the control cells grown in plastic culture plates (data not shown).
Expression of the uPA and N-ras genes in PU.1-transfected HT1080 cells
It has been reported that the activated N-ras gene is crucial for keeping the transformed phenotypes of HT1080 cells (Hall et al, 1983; Paterson et al, 1987) and that the elevated levels of expression of urokinase-type plasminogen activator (uPA) are associated with cell migration and malignant transformation in several types of tumour cells (Kirchheimer and Remold, 1989; Chambers et al, 1995) . Therefore, we examined whether PU. 1 could affect expression of these genes in HT1080 NM-l cells. As shown in Figure  3A , NMPU. 1-7 and NMPU. Figure 3A ). This was also true in another series of transfectants (LRPU. 1-6, LRPU. 1-9, LRPU. 1-14 and LRPU. 1-15) established by transfecting the PU. I expression vector into another HT1080 subclone, cl-2 (compare lanes 1 and 3 with lanes 5, 7, 9 and 11 in Figure 3B ).
Effect of glucocorticoid on uPA expression and cell migration in HT1080 cells Figure 4 Nuclear run-on analysis of the uPA (U) and actin (A) genes in mock-transfected (vector) and PU. 1-transfected LRPU.1-15 cells untreated (-) or treated (+) with 10-7 of DEX for 24 h. The signal specific for the uPA gene was compared as a ratio of the intensity with that of the actin gene used as an internal control level in HT1080 cells (Medcalf et al, 1986) . Furthermore, transcriptional interference between PU. 1 and steroid/vitamin receptor family members has been reported in vitro using the chloramphenicol acetyltransferase (CAT) assay (Gauthier et al, 1993) . Therefore, we examined whether expression of PU. I interferes with the effect of DEX on uPA expression in vivo in HT1080 cells. As shown in Figure 3A and B, treatment of HT1080 cells and mock transfectants with 10-M of DEX greatly reduced uPA mRNA levels in these cells. Although a decrease in the level of uPA transcripts was also observed in PU.l-transfected cells after treatment with DEX, the levels were still higher than those in parental and mock-transfected control cells without DEX treatment. Densitometric analysis revealed that the levels were reduced to 80%, 62%, 73% and 40% in NMPU. 1-7, NMPU. 1-8-1, NMPU. l-1 -L and NMPU. 1-26 cells, whereas they were reduced to 40% and 50% in parental and mock-transfected NM-1 cells respectively ( Figure 3A ). In the same context, DEX reduced the levels of uPA mRNA to 60%, 33%, 55% and 87% in LRPU.1-6, LRPU.l-9, LRPU.1-14 and LRPU.1-15 cells, but to less than 10% in control cl-2 cells, respectively ( Figure 3B ). In contrast, DEX did not affect N-ras gene expression in these PU. I-expressing cells as well as the control cells. In HT 1080 cells, DEX seemed to increase slightly rather than decrease expression of the transfected PU. I gene. These results indicate that DEX specifically reduced uPA expression in HT 1080 cells but the degree of reduction was alleviated by expression of the PU. I gene. The effect of DEX on growth properties of PU.I transfectants was then examined. Neither cell growth in adherent culture nor colony formation in soft agar of HT1080 cells was inhibited even in the presence of DEX (data not shown). Microscopic examination of the colonies in soft agar showed that parental and mocktransfected HT 1080 NM-1 cells formed tight and more compact confines without cell spreading in soft agar in the presence of DEX compared with the colonies in the absence of DEX (compare A with C in Figure 2 ). On the other hand, PU. I transfectants failed to form compact colonies, although cell spreading was much reduced in the presence of DEX (compare C with D, and B with D in Figure 2 ). These results suggest that DEX reduces cell motility and/or enhances cell-cell adhesion and that ectopic expression of PU. 1 alleviates the effect of DEX in HT 1080 cells.
Transcriptional and post-transcriptional control of the uPA gene by ectopic expression of PU.1 and DEX treatment in HT1080 cells
In order to examine whether the effects of PU. 1 and DEX on uPA expression occurred at the transcriptional level, a nuclear run-on assay was performed using nuclei isolated from PU. I-transfected and mock-transfected cells in the presence or absence of DEX. LRPU. 1-15 was chosen as a representative PU. I transfectant because of the highest expression of uPA mRNA among the isolated clones. A mock-transfected clone was used as a control. As shown in Figure 4 , the levels of uPA transcription were very similar in both cells, although the accumulation of uPA mRNA was significantly higher in LRPU. 1-15, compared with mock-transfected cells. The levels of the actin transcription, examined as a control gene, were almost the same between control and LRPU. 1-15 cells. Northern blot analysis demonstrated that levels of actin mRNA were also unchanged between the two (data not shown). On the other hand, the relative level of uPA transcription in mock-transfected cells, as judged in comparison with the level of actin transcription, was significantly reduced to 25% by DEX treatment, whereas in LRPU.1-15 cells it was merely reduced to 88%. The actin transcription was not reduced by DEX in both cells. These results suggest that the transcription rate of the uPA gene was unaffected by PU. 1 in the absence of DEX and that increase in steadystate level of uPA mRNA by PU.1 is mainly accounted for by post-transcriptional control. Meanwhile, transcription of the uPA gene was markedly reduced by DEX treatment. The negative effect of DEX on the uPA transcription was, however, significantly alleviated by expression of PU. 1 in HT1080 cells.
DISCUSSION
We found that exogenous expression of PU.l in HT1080 human fibrosarcoma cells increased cell migration in soft agar. In association with these cell biological changes, expression of the uPA mRNA, which encodes a serine protease correlated with cell migration and invasion, was enhanced in PU. l-transfected HT1080 cells compared with mock transfectants. The uPA gene has a transcriptional enhancer region, which consists of binding sites for Fos/Jun family transcription factors AP-1 and an Ets family transcription factor PEA3, and this region has been reported to be critical for activation of the gene in HT1080 cells (Nerlov et al, 1991) . In murine macrophages, Ets-2 activates the uPA enhancer by binding to the PEA3 site, whereas other Ets family transcription factors such as PU. I and PEA3 do not activate the enhancer (Stacey et al, 1995 (Henderson et al, 1991 ; uPA mRNA stability is specifically increased by a synergistic effect of Ca2+ and cAMP in renal epithelial cells (Altus et al, 1987 (Altus et al, , 1991 Zeigler et al, 1990) ; and cycloheximide, an inhibitor of protein synthesis, increases the uPA mRNA half-life from 70 min to >20 h (Altus et al, 1991) . Therefore, there may be a protein(s) of shorthalf life, potentially attaching to the A+U-rich elements in the 3'-untranslated region of the uPA mRNA and responsible for specific degradation of the mRNA (Altus et al, 1991; Henderson and Kefford 1991) . PU. I may affect the level and/or function of such proteins.
There are several reports showing that glucocorticoid can lower uPA activity in a number of cell types (Littlefield et al, 1985; Medcalf et al, 1986) . Consistent with previous reports by others (Medcalf et al, 1986) , our results suggest that the suppression of the uPA gene expression by DEX occurs at the transcriptional level in HT1080 cells. Furthermore, we demonstrate that DEX antagonized the effect of PU. I on morphology of colonies grown in soft agar: PU. I stimulated cell migration, whereas DEX inhibited it. In parallel with this, PU. 1 alleviated the negative effect of DEX on uPA expression at the transcriptional level in HT 1080 cells. It has been reported that the glucocorticoid receptor (GR) interferes with the function of PU. 1 and vice versa in human breast cancer cells (Gauthier et al, 1993) . Similar mutual functional interference between Fli-1, another ETS family protein, and steroid hormone receptors was also reported recently (Darby et al, 1997) . Therefore, our observation may be accounted for by such a functional interference, by which PU. I blocks the transcriptional suppressing activity of GR in HT 1080 cells.
We also found that PU. 1 brought about negative effects upon the anchorage-independent growth of HT1080 cells: the PU.] transfectants exhibited reduced colony formation in soft agar. Similar observations have been reported in some tumours: constitutive expression of Ets-1 reverts the tumorigenicity in human colon cancer cells (Suzuki et al, 1996) and stable expression of a transdominant mutant of PU.1 or Ets-2 also reverts Ras-transformed NIH/3T3 cells (Langer et al, 1992; Wasylyk et al, 1994) . It is known that HT1080 cells harbour the activated N-ras oncogene, which is essential for maintaining the transformed phenotypes of the cells, and inhibition of N-ras gene expression rendered the cells less malignant (Hall et al, 1983; Paterson et al, 1987) . However, PU.1-transfected HT1080 cells expressed similar levels of N-ras mRNA to the parental cells and mock transfectants ( Figure 3A and B) . As a member of the Ets family proteins is one of the nuclear targets of the ras signalling pathway to activate rasresponsive elements (Wasylyk et al, 1990; Galang et al, 1994) , the ectopic expression of PU. I may perturb endogenous Ets family proteins, which mediate the ras signals crucial for maintenance of the transformed phenotypes of HT1080 cells.
In conclusion, our results could provide an insight into a novel function of Ets-related transcription factor PU. I on several transformed phenotypes provoked, in part, by the activated N-ras oncogene.
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